Volitionrx (VNRX) Non-Current Receivables (2018 - 2019)
Volitionrx posted quarterly Non-Current Receivables of $301784.0 for Q2 2019, down 2.98% on a QoQ basis from $311042.0 in Q4 2018.
Volitionrx (VNRX) has 2 years of Non-Current Receivables data on file, last reported at $301784.0 in Q2 2019.
- For the quarter ending Q2 2019, Non-Current Receivables changed N/A year-over-year to $301784.0; the trailing twelve-month figure through Jun 2019 stood at $301784.0 (changed N/A YoY), and the FY2018 full-year result was $311042.0, changed N/A from the prior year.
- Non-Current Receivables for Q2 2019 stood at $301784.0, down from $311042.0 in the prior quarter.
- Across five years, Non-Current Receivables topped out at $311042.0 in Q4 2018 and bottomed at $301784.0 in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 257.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 301,784.00 |
| Dec 31, 2018 | 311,042.00 |